You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 28, 2024

ACETYLCHOLINE CHLORIDE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for acetylcholine chloride and what is the scope of patent protection?

Acetylcholine chloride is the generic ingredient in two branded drugs marketed by Novartis and Bausch And Lomb, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for acetylcholine chloride. One supplier is listed for this compound.

Summary for ACETYLCHOLINE CHLORIDE
US Patents:0
Tradenames:2
Applicants:2
NDAs:2
Drug Master File Entries: 3
Finished Product Suppliers / Packagers: 1
Raw Ingredient (Bulk) Api Vendors: 106
Clinical Trials: 10
Patent Applications: 2,192
What excipients (inactive ingredients) are in ACETYLCHOLINE CHLORIDE?ACETYLCHOLINE CHLORIDE excipients list
DailyMed Link:ACETYLCHOLINE CHLORIDE at DailyMed
Recent Clinical Trials for ACETYLCHOLINE CHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Yuria-PharmPhase 4
Virginia Commonwealth UniversityPhase 4
Seoul National University HospitalN/A

See all ACETYLCHOLINE CHLORIDE clinical trials

Medical Subject Heading (MeSH) Categories for ACETYLCHOLINE CHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for ACETYLCHOLINE CHLORIDE

US Patents and Regulatory Information for ACETYLCHOLINE CHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bausch And Lomb MIOCHOL-E acetylcholine chloride FOR SOLUTION;OPHTHALMIC 020213-001 Sep 22, 1993 RX Yes Yes ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Novartis MIOCHOL acetylcholine chloride FOR SOLUTION;OPHTHALMIC 016211-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

ACETYLCHOLINE CHLORIDE Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for Acetylcholine Chloride

Introduction to Acetylcholine Chloride

Acetylcholine chloride is a crucial neurotransmitter that acts on both nicotinic and muscarinic acetylcholine receptors, playing a vital role in muscle and neurological processes. Its significance in biological systems has driven extensive research and development, particularly in the pharmaceutical and neuroscience sectors.

Market Size and Growth Projections

The acetylcholine market, which includes acetylcholine chloride, was valued at USD 1.45 billion in 2023 and is projected to reach USD 2.85 billion by 2031, growing at a Compound Annual Growth Rate (CAGR) of 6.2% from 2024 to 2031[1].

Key Drivers of Market Growth

Several factors are driving the growth of the acetylcholine chloride market:

Increasing Incidence of Neurological Disorders

The rising prevalence of neurological conditions such as Alzheimer's disease, Parkinson's disease, and myasthenia gravis has increased the demand for acetylcholine-based therapies. This trend is expected to continue, fueled by an aging population that is more susceptible to these disorders[1].

Advancements in Pharmaceutical and Neuroscience R&D

Significant investments in pharmaceutical and neuroscience research and development are leading to the discovery of new therapeutic applications for acetylcholine chloride. This includes the development of drugs targeting acetylcholine receptors (AChR) for various indications such as primary axillary hyperhidrosis, muscle hypertonia, and Alzheimer's disease[3].

Technological and Scientific Breakthroughs

Technological advancements in biotechnology and neurology are generating novel therapeutic uses for acetylcholine chloride. These breakthroughs are expanding the market by providing new treatment options for a range of neurological and musculoskeletal disorders[1].

Aging Population and Healthcare Improvements

The aging population is a significant driver, as older individuals are more prone to neurological and musculoskeletal disorders. Additionally, improving healthcare facilities and increasing awareness of neurological health in developing countries are contributing to market growth[1].

Market Segmentation

The acetylcholine chloride market is segmented based on several criteria:

Type

The market is categorized into Acetylcholine Chloride and Acetylcholine Bromide. Acetylcholine chloride is the more commonly used form due to its stability and efficacy in various applications[1].

Application

Key applications include:

  • Neurotransmission Studies: Acetylcholine chloride is used extensively in research to understand neurotransmission mechanisms.
  • Drug Discovery Research: It is a critical component in the development of new drugs targeting AChR.
  • Ophthalmic Applications: Used in treatments related to eye health.
  • Other Biological & Pharmaceutical Uses: Includes various other medical and research applications[1].

Geographical Regions

The market is segmented into North America, Europe, Asia-Pacific, South America, and the Middle-East and Africa. The Asia-Pacific region is a significant market due to its large population and growing healthcare sector[1].

Competitive Landscape

The competitive landscape of the acetylcholine chloride market is characterized by the presence of several key players:

Major Companies

Companies such as Sigma-Aldrich, Merck KGaA, TCI Chemicals, Alfa Aesar, and Tokyo Chemical Industry Co., Ltd. are prominent in the market. These companies are involved in the production and supply of high-quality acetylcholine chloride for various applications[1].

Research and Development

Companies like Bausch Health Cos., Inc., AbbVie, Inc., and Alcon AG are actively involved in the research and development of drugs targeting AChR. These efforts are driving the market forward with new therapeutic applications and indications[3].

Financial Trajectory

The financial trajectory of the acetylcholine chloride market is positive, driven by the factors mentioned above.

Revenue Growth

The market is expected to grow from USD 1.45 billion in 2023 to USD 2.85 billion by 2031, indicating a robust financial outlook[1].

Investments and Funding

Significant investments in R&D and the expansion of product lines by major players are expected to continue, supporting the market's financial growth. The increasing demand from pharmaceutical and neuroscience sectors ensures a stable and growing revenue stream[1].

Challenges and Opportunities

Challenges

  • Regulatory Hurdles: Strict regulatory requirements can slow down the approval process for new drugs and therapies.
  • Market Competition: The market is competitive, with multiple players vying for market share.
  • Economic Factors: Economic downturns or global health crises, such as the COVID-19 pandemic, can impact market growth[1].

Opportunities

  • Emerging Markets: Growing healthcare needs in developing countries present significant opportunities for market expansion.
  • Technological Advancements: Continuous advancements in biotechnology and neurology offer new avenues for the application of acetylcholine chloride.
  • Increasing Demand for Supplements: The growing demand for nutritional supplements, particularly those related to brain health and muscle function, can further boost the market[1][4].

Key Takeaways

  • The acetylcholine chloride market is projected to grow significantly due to increasing demand driven by neurological disorders and advancements in R&D.
  • The market is segmented by type, application, and geographical region, with the Asia-Pacific region being a key market.
  • Major companies are investing heavily in R&D and expanding their product lines to cater to growing demand.
  • Despite challenges, the market presents several opportunities for growth, particularly in emerging markets and through technological advancements.

Frequently Asked Questions (FAQs)

1. What is the projected market size of the acetylcholine chloride market by 2031?

The acetylcholine chloride market is expected to reach USD 2.85 billion by 2031[1].

2. What are the key drivers of the acetylcholine chloride market?

Key drivers include the increasing incidence of neurological disorders, advancements in pharmaceutical and neuroscience R&D, technological breakthroughs, and an aging population[1].

3. Which region is the largest market for acetylcholine chloride?

The Asia-Pacific region is the largest market for acetylcholine chloride and is expected to remain so during the forecast period[1].

4. Who are the major players in the acetylcholine chloride market?

Major players include Sigma-Aldrich, Merck KGaA, TCI Chemicals, Alfa Aesar, and Tokyo Chemical Industry Co., Ltd.[1].

5. What are the primary applications of acetylcholine chloride?

Primary applications include neurotransmission studies, drug discovery research, ophthalmic applications, and other biological and pharmaceutical uses[1].

Cited Sources:

  1. Market Research Intellect - Global Acetylcholine Sales Market Size, Scope And Forecast Report[1].
  2. Tocris Bioscience - Acetylcholine chloride[2].
  3. Synapse by Patsnap - Deep Scientific Insights on acetylcholine chloride's R&D Progress[3].
  4. Mordor Intelligence - Choline Chloride Market Size & Share Analysis[4].

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.